MedTrace Logo

NGS-based Large-panel in Targeted Drug Delivery and Immunotherapy of Lung Cancer

NCT04159337 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2019-11-12

No results posted yet for this study

Summary

Companion diagnosis by large-panel is in increasing acceptance and need during clinical cancer management. The purpose of this trial is to investigate the benefit of large-panel NGS analysis in companion diagnosis of advanced lung cancer patients and further optimize the parameters.

Conditions

  • Lung Neoplasms

Interventions

OTHER

The method of gene mutation detection

All samples were detected by large-panel, whereas some of which were also detected by WES.

Sponsors & Collaborators

  • Shanghai Chest Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-30
Primary Completion
2022-01-01
Completion
2022-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04159337 on ClinicalTrials.gov